T. Rowe Price Associates’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-2,823
| Closed | -$140K | – | 3014 |
|
|
2022
Q1 | $140K | Buy |
2,823
+450
| +19% | +$22.3K | ﹤0.01% | 2781 |
|
|
2021
Q4 | $179K | Buy |
2,373
+890
| +60% | +$67.1K | ﹤0.01% | 2780 |
|
|
2021
Q3 | $117K | Hold |
1,483
| – | – | ﹤0.01% | 2815 |
|
|
2021
Q2 | $206K | Buy |
1,483
+75
| +5% | +$10.4K | ﹤0.01% | 2714 |
|
|
2021
Q1 | $295K | Buy |
1,408
+12
| +0.9% | +$2.51K | ﹤0.01% | 2567 |
|
|
2020
Q4 | $232K | Hold |
1,396
| – | – | ﹤0.01% | 2516 |
|
|
2020
Q3 | $237K | Buy |
+1,396
| New | +$237K | ﹤0.01% | 2369 |
|